Emzale-I

Description

Emzale-I is a combination formulation containing esomeprazole magnesium 40 mg, provided as enteric-coated pellets, and itopride hydrochloride 150 mg. Esomeprazole reduces stomach acid production, while itopride helps support upper gastrointestinal motility.

Healthcare professionals may consider this combination for selected acid-related gastrointestinal conditions accompanied by symptoms associated with impaired gastric motility, when both ingredients are clinically appropriate.

Emzale-I is listed in the General Physician (G.P.) and Gynae product segments and is supplied in Alu-Alu packaging of 10 × 10 units. It should be used according to the approved product information and professional advice.

Therapeutic Segment

Gastroenterology | Acid-Related Disorders | Gastrointestinal Motility

Uses of Emzale-I

A healthcare professional may consider Emzale-I for selected patients with:

• Acid-related upper gastrointestinal symptoms requiring acid suppression.
• Gastro-oesophageal reflux symptoms, when the formulation is appropriate.
• Upper gastrointestinal discomfort associated with delayed gastric motility, where itopride is clinically indicated.
• Combined acid-related and motility symptoms requiring individualised assessment.

The appropriate indication depends on the patient’s diagnosis, medical history and the approved product label. Not every case of acidity, bloating or indigestion requires a combination medicine.

Key Benefits

• Acid Suppression: Esomeprazole reduces gastric acid secretion.
• Gastrointestinal Motility Support: Itopride promotes upper gastrointestinal motility through its pharmacological actions.
• Complementary Mechanisms: The two ingredients act through different pathways.
• Enteric-Coated Pellets: The supplied composition identifies esomeprazole magnesium in enteric-coated pellet form.
• Convenient Packaging: Supplied in Alu-Alu packaging of 10 × 10 units.

Individual results vary, and treatment benefits depend on the underlying condition and suitability of the formulation.

How Emzale-I Works

Esomeprazole magnesium belongs to the proton pump inhibitor (PPI) class. It suppresses the gastric proton pump in stomach cells, reducing acid secretion. The enteric coating helps protect the acid-sensitive ingredient during passage through the stomach.

Itopride hydrochloride acts through dopamine D2 receptor antagonism and acetylcholinesterase inhibition. These actions can enhance gastrointestinal motility and help support stomach emptying in selected patients.

Possible Side Effects

Possible side effects may include:

• Headache.
• Abdominal discomfort.
• Nausea.
• Diarrhoea or constipation.
• Dizziness.
• Changes in bowel habits.

Side effects vary between individuals. Seek medical advice if symptoms persist, worsen or interfere with daily activities. Obtain urgent medical assessment for severe allergic symptoms or other serious reactions.

Important Safety Information

• Medical supervision: Use Emzale-I according to the approved label and advice from a qualified healthcare professional.
• Medical history: Inform your healthcare professional about liver or kidney problems, other medical conditions and all medicines or supplements you take.
• Drug interactions: Esomeprazole and itopride may interact with certain medicines. Have your current medication list reviewed before use.
• Pregnancy and breastfeeding: Seek medical advice before taking this combination.
• Persistent symptoms: Recurrent vomiting, difficulty swallowing, unexplained weight loss, gastrointestinal bleeding or severe abdominal pain require prompt medical evaluation.
• Avoid self-medication: Do not increase the dose or extend the treatment period without professional advice.

Dosage and Administration

Take Emzale-I only as directed by the prescribing healthcare professional and approved product label. The appropriate dose, timing and duration depend on the diagnosis, patient factors and formulation instructions.

Follow the label’s instructions for administration. Do not crush or chew enteric-coated pellets unless the approved product information specifically permits it.

Storage Instructions

Store Emzale-I according to the conditions stated on the approved product label. Keep the product in its original packaging, away from children, and do not use it after the expiry date.